Business

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure. Advisor Program Driving Utilization and Real-World Data Generation Since launching the CompuFlo® Advisor Program in

articleMilestone Scientific, Inc.May 7, 20262/company/milestone-scientific-inc/news/milestone-scientific-expands-compuflor-medical-business-with-advisor-program-and-growing-national-clinical-adoption
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

About this update from Milestone Scientific, Inc.

[{"type":"image","alt":"Milestone Scientific, Inc.","displaySize":"","headline":null,"caption":"Milestone Scientific, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":65,"url":"https://media.zenfs.com/en/globenewswire.com/2153125b7314814c812953238fb1ca11"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pYAYMPxRv4_7h7yMj8t5mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkx/https://media.zenfs.com/en/globenewswire.com/2153125b7314814c812953238fb1ca11","width":300,"height":65},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/pYAYMPxRv4_7h7yMj8t5mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkx/https://media.zenfs.com/en/globenewswire.com/2153125b7314814c812953238fb1ca11","width":300,"height":65}},"lazy":false},{"type":"text","content":"ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure.","length":384,"tagName":"p"},{"type":"text","content":"Advisor Program Driving Utilization and Real-World Data Generation","length":66,"tagName":"p"},{"type":"text","content":"Since launching the CompuFlo® Advisor Program in February 2026, the Company has onboarded physician advisors and initiated procedural use across key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast Service Options, and Palmetto, as well as select commercial payers.","length":303,"tagName":"p"},{"type":"text","content":"The program is currently active in NJ, FL, PA, NY, TN, TX, and GA, with expansion into additional MAC regions underway, including Noridian and NGS.","length":147,"tagName":"p"},{"type":"text","content":"• Active epidural procedures being performed using CompuFlo®• Initial cases submitted across Medicare and commercial payers• Continued onboarding of physician advisors","length":169,"tagName":"p"},{"type":"text","content":"Milestone is executing a structured roadmap to expand clinical utilization, support real-world data generation, and enhance payer engagement, with a scalable recurring revenue model driven by disposables.","length":204,"tagName":"p"},{"type":"text","content":"Building the F...

More updates from Milestone Scientific, Inc.

Milestone Scientific Inc.Medicare Administrative Contractorcommercial infrastructureMilestone Scientific IncMilestone ScientificAdvisor Programclinical validationphysician utilizationAmerican Medical Association